Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Behavioral Sleep Medicine|April 20, 2007
Brief behavioral therapies reduce early positive airway pressure discontinuation rates in sleep apnea syndrome: preliminary findingsMark S Aloia, Kevin Smith, J Todd Arnedt, et al.
American Journal of Respiratory and Critical Care Medicine|January 1, 1997
Effects of menopause and nasal occlusion on breathing during sleepM A Carskadon, H M Bearpark, K M Sharkey, et al.
The American Review of Respiratory Disease|December 1, 1991
Nocturnal positive-pressure ventilation via nasal mask in patients with severe chronic obstructive pulmonary diseaseD A Strumpf, R P Millman, C C Carlisle, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|August 30, 2008
Time series analysis of treatment adherence patterns in individuals with obstructive sleep apneaMark S Aloia, Matthew S Goodwin, Wayne F Velicer, et al.
Sleep Medicine|April 15, 2014
Airflow limitations in pregnant women suspected of sleep-disordered breathingGhada Bourjeily, Jennifer Y Fung, Katherine M Sharkey, et al.
Sleep|February 13, 2019
Pulse transit time in pregnancy: a new way to diagnose and classify sleep disordered breathing?Brittany N Link, Celine Eid, Maggie H Bublitz, et al.
Chest|June 19, 2007
The impact of cardiac resynchronization therapy on obstructive sleep apnea in heart failure patients: a pilot studyMichael L Stanchina, Kristin Ellison, Atul Malhotra, et al.
Undersea & Hyperbaric Medicine : Journal of the Undersea and Hyperbaric Medical Society, Inc|August 2, 2017
Applying quality improvement methods in a hyperbaric oxygen program: reducing unnecessary glucose testingSarah L Stevens, Atsushi Sorita, Anthony J Narr, et al.
Undersea & Hyperbaric Medicine : Journal of the Undersea and Hyperbaric Medical Society, Inc|July 9, 2015
The incidence of hypoglycemia during HBO2 therapy: A retrospective reviewSarah L Stevens, Anthony J Narr, Paul L Claus, et al.
Clinical and Experimental Immunology|March 24, 2020
Exogenous interleukin-2 can rescue in-vitro T cell activation and proliferation in patients with a novel capping protein regulator and myosin 1 linker 2 mutationO Shamriz, A J Simon, A Lev, et al.
Pageof 10